Lv3
248 积分 2024-12-13 加入
Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
3天前
已完结
Real World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn's Disease
7天前
已完结
Clinical and Genetic Factors Impact Time to Surgical Recurrence After Ileocolectomy for Crohn's Disease
7天前
已完结
Clinical and Genetic Factors Impact Time to Surgical Recurrence After Ileocolectomy for Crohn's Disease
7天前
已完结
Which Patients Benefit from Biologic Agents to Prevent Disease Recurrence After Resection in Crohn's Disease?
8天前
已完结
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
12天前
已完结
Differentiating IL-23 Inhibitors in Crohn’s Disease
12天前
已完结
Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn’s disease
15天前
已完结
Combined Clinical and Histopathological Risk Stratification for Prediction of (severe) Endoscopic Postoperative Recurrence in Patients with Crohn’s Disease after Ileocolic Resection
26天前
已完结
Shaping the future of postoperative recurrence in Crohn’s disease: personalised approaches with AI-enabled imaging and multi-omics
26天前
已完结
皖公网安备34019202002308
